CDK1 and colonic neoplasm: Physical interaction of NOSTRIN with Cdk1 was therefore, tested in colon cancer cells using immunoprecipitation with anti-Cdk1 (Cdc2) antibody followed by western blotting using anti-NOSTRIN antibody.